CYP3A4 inhibitors increase the effect unpredictably. The likelihood of adverse events increases antiarrhythmics (classes IA and III), tricyclic antidepressants (amitriptyline) and tetracyclic (maprotiline), antipsychotics (phenothiazines, pimozid, sertindol) and antihistamines (astemizole, terfenadine).
Abdominal pain, transient, intestinal spasms, rumbling, diarrhea, headache, dizziness, arrhythmia, including ventricular tachycardia, ventricular fibrillation, torsades de points, lengthening of QT, liver disorders, pollakiuria (when applied in high doses), allergic reactions (itching, rash, urticaria, bronchospasm).
Gastric and intestinal paresis, gastric dyspepsia, reflux esophagitis, chronic constipation, regurgitation in newborns.
It increases the tone and motor activity of the gastrointestinal tract, increases the tone of the sphincter of the lower esophagus and prevents the release of the contents of the stomach. It accelerates the emptying of the stomach and duodenum, the advancement of food through the small and large intestine, prevents food stasis and duodenum-gastral reflux.
Cipasid
Cisapride
Inside. The dosage is set individually. Adult: 5-20 mg 2-4 times a day.
Child: by 0.15-0.3 mg / kg of body weight 2-3 times a day.
